1. Home
  2. SNWV vs MRVI Comparison

SNWV vs MRVI Comparison

Compare SNWV & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNWV
  • MRVI
  • Stock Information
  • Founded
  • SNWV 2004
  • MRVI 2014
  • Country
  • SNWV United States
  • MRVI United States
  • Employees
  • SNWV N/A
  • MRVI N/A
  • Industry
  • SNWV
  • MRVI Biotechnology: Pharmaceutical Preparations
  • Sector
  • SNWV
  • MRVI Health Care
  • Exchange
  • SNWV NYSE
  • MRVI Nasdaq
  • Market Cap
  • SNWV 239.4M
  • MRVI 262.9M
  • IPO Year
  • SNWV N/A
  • MRVI 2020
  • Fundamental
  • Price
  • SNWV $30.90
  • MRVI $2.07
  • Analyst Decision
  • SNWV
  • MRVI Hold
  • Analyst Count
  • SNWV 0
  • MRVI 9
  • Target Price
  • SNWV N/A
  • MRVI $6.54
  • AVG Volume (30 Days)
  • SNWV 60.5K
  • MRVI 2.1M
  • Earning Date
  • SNWV 05-12-2025
  • MRVI 05-12-2025
  • Dividend Yield
  • SNWV N/A
  • MRVI N/A
  • EPS Growth
  • SNWV N/A
  • MRVI N/A
  • EPS
  • SNWV N/A
  • MRVI N/A
  • Revenue
  • SNWV $32,634,000.00
  • MRVI $259,185,000.00
  • Revenue This Year
  • SNWV N/A
  • MRVI N/A
  • Revenue Next Year
  • SNWV N/A
  • MRVI $14.23
  • P/E Ratio
  • SNWV N/A
  • MRVI N/A
  • Revenue Growth
  • SNWV 59.99
  • MRVI N/A
  • 52 Week Low
  • SNWV $25.23
  • MRVI $1.67
  • 52 Week High
  • SNWV $39.50
  • MRVI $11.56
  • Technical
  • Relative Strength Index (RSI)
  • SNWV N/A
  • MRVI 46.96
  • Support Level
  • SNWV N/A
  • MRVI $1.96
  • Resistance Level
  • SNWV N/A
  • MRVI $2.21
  • Average True Range (ATR)
  • SNWV 0.00
  • MRVI 0.12
  • MACD
  • SNWV 0.00
  • MRVI 0.07
  • Stochastic Oscillator
  • SNWV 0.00
  • MRVI 75.00

About SNWV SANUWAVE HEALTH INC

SANUWAVE Health Inc is an ultrasound and shock wave technology company using patented systems of noninvasive, high-energy, acoustic shock waves or low-intensity and non-contact ultrasound for regenerative medicine and other applications. The company's focus is regenerative medicine utilizing noninvasive, acoustic shock waves or ultrasound to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's two primary systems are UltraMIST and PACE. UltraMIST and PACE are the only two Food and Drug Administration (FDA) approved directed energy systems for wound healing.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: